Results 231 to 240 of about 2,805,991 (295)

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

Big Five Personality Traits, Personal Projects, and Compulsive Buying: A Causal Approach. [PDF]

open access: yesEur J Investig Health Psychol Educ
Otero-López JM, Santiago MJ, Castro MC.
europepmc   +1 more source

Effectiveness of Multiple Mini Interviews in medical school admissions: assessment using The Big Five Personality framework. [PDF]

open access: yesEinstein (Sao Paulo)
Góes JS   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy